The Mayo Orbital Radiotherapy for Graves Ophthalmopathy (ORGO) Study: Lessons Learned

G. Bartley,C. Gorman
DOI: https://doi.org/10.1097/00002341-200205000-00002
2002-05-01
Ophthalmic Plastic and Reconstructive Surgery
Abstract:Graves orbitopathy remains elusive, and we lack a “silver bullet” to precisely and selectively target its pathophysiology. As clinicians, we continue to search for the best available management strategy for some very debilitated and unhappy patients. A recent report from the Mayo Clinic raised questions about one of the widely used weapons in that therapeutic arsenal. Ophthalmic Plastic and Reconstructive Surgery invited the authors of that study to address some of those issues. To broaden the discussion, we sought perspectives from two other centers with wide experience in treating Graves orbitopathy: Columbia University and the University of Amsterdam.—G.J.H.]
What problem does this paper attempt to address?